Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Entirely Remote 2-Week Integrated Treatment for Pain and PTSD

NCT07116109 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT07116109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07116109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Entirely Remote 2-Week Integrated Treatment for Pain and PTSD
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2025
Completion date
June 30, 2029
Enrollment
146 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, post traumatic stress disorder (ptsd)